| (USD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 37.67M | — |
| Operating expense | — | — |
| Net income | -5.49M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, HRTX returned -77.1% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -75.4% |
| 1 year | -77.1% |
| 5 years | -97.3% |
| 10 years | -98.3% |
| All-time high | $1,090.00 (Jan 1992) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in HRTX would be worth today ›No. Heron Therapeutics, Inc. has not paid a dividend in the past 12 months.
Heron Therapeutics, Inc. stock trades on NASDAQ under the ticker symbol HRTX.
Heron Therapeutics, Inc. is part of the Healthcare sector.
Heron Therapeutics, Inc. has a market cap of 60.41M USD, based on the latest quote.
Heron Therapeutics, Inc. is scheduled to report earnings on Nov 3, 2026.
